BRIEF-Concert Pharmaceuticals announces positive data from phase 1 of CTP-656
April 28, 2016 at 16:23 PM EDT
* Announces Positive Data From Multiple Dose Phase 1 Clinical Trial Of Ctp-656, lead candidate for the treatment of cystic fibrosis